Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?

Some trials have shown an overall benefit of low-intensity extracorporeal shockwave therapy (LI-ESWT) for erectile dysfunction, while others have been unable to find differences between LI-ESWT and sham treatment. In the absence of definitive evidence, patients should only be offered LI-ESWT in an investigational setting or on an off-label basis with a thorough understanding of the risks and benefits.

European urology focus. 2019 Feb 15 [Epub ahead of print]

Premal Patel, Mikkel Fode, Tom Lue, Ranjith Ramasamy

Department of Urology, University of Miami, Miami, FL, USA., Department of Urology, Herlev and Gentofte Hospital, Herlev, Denmark., Department of Urology, University of California, San Francisco, San Francisco, CA, USA., Department of Urology, University of Miami, Miami, FL, USA. Electronic address: .